What is the address of PHARMAPRO?

The registered office of PHARMAPRO is located at Auenweg 11, 4700 Eupen.

Is PHARMAPRO still active?

Yes. According to the CBE (30 October 2026) PHARMAPRO is active, legal situation “Normale toestand”, started on 22 July 1997.

Is PHARMAPRO registered on Peppol?

No, PHARMAPRO is currently not registered on the Peppol network.

What is the enterprise number of PHARMAPRO?

The enterprise number of PHARMAPRO is BE0461179570.

When was PHARMAPRO founded?

PHARMAPRO was founded on 22 July 1997.

The shares are held by PROBELPHARMA (48.3%). It owns Pharma Goedert itself.

Is PHARMAPRO a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 22 July 1997; 5 annual accounts filed, latest fiscal year 2025.

How much profit did PHARMAPRO make in 2025?

PHARMAPRO posted a profit after taxes of € 252,816 in financial year 2025.

What is the revenue of PHARMAPRO?

As a small company, PHARMAPRO is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -3,341.

PHARMAPRO (Public Limited) - Eupen - BE0461179570

Dossier PHARMAPRO, printed on 30 October 2026 from databakkes.be/en/0461179570/pharmapro. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

PHARMAPRO from Eupen, company number BE0461179570, closed financial year 2025 with a result of € 252,816 after tax. For that financial year PHARMAPRO recorded a gross margin of € -3,341 and equity of € 3.5 million. Compared with financial year 2024, the result moved from € 138,463 to € 252,816. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 10, 2026.

What it is worth Healthy

€ 3.5 million

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 252,816

▲ 83% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 1.2 million

▲ 28% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 255,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 4,697

▲ 201% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ -4,545 Gross margin 2022: € -4,545 First fiscal year in the series	€ -3,493 Gross margin 2023: € -3,493 ▲ € 1,052 vs 2022 (€ -4,545) Favourable step	€ -3,534 Gross margin 2024: € -3,534 ▼ € 41 vs 2023 (€ -3,493) Unfavourable step	€ -3,341 Gross margin 2025: € -3,341 ▲ € 192 vs 2024 (€ -3,534) Favourable step	▲ € 192
Profit after taxes	€ 92,320 Profit after taxes 2022: € 92,320 First fiscal year in the series	€ 94,786 Profit after taxes 2023: € 94,786 ▲ 3% vs 2022 (€ 92,320) Favourable step	€ 138,463 Profit after taxes 2024: € 138,463 ▲ 46% vs 2023 (€ 94,786) Favourable step	€ 252,816 Profit after taxes 2025: € 252,816 ▲ 83% vs 2024 (€ 138,463) Favourable step	▲ 83%
Equity	€ 3,249,050 Equity 2022: € 3,249,050 First fiscal year in the series	€ 3,343,836 Equity 2023: € 3,343,836 ▲ 3% vs 2022 (€ 3,249,050) Favourable step	€ 3,482,299 Equity 2024: € 3,482,299 ▲ 4% vs 2023 (€ 3,343,836) Favourable step	€ 3,480,115 Equity 2025: € 3,480,115 Unchanged (€ 3,482,299) Unfavourable step
Total debts	€ 6,510 Total debts 2022: € 6,510 First fiscal year in the series	€ 4,384 Total debts 2023: € 4,384 ▼ 33% vs 2022 (€ 6,510) Favourable step	€ 1,559 Total debts 2024: € 1,559 ▼ 64% vs 2023 (€ 4,384) Favourable step	€ 259,697 Total debts 2025: € 259,697 ▲ € 258,138 vs 2024 (€ 1,559) Unfavourable step	▲ € 258,138
Cash	€ 499,711 Cash 2022: € 499,711 First fiscal year in the series	€ 592,370 Cash 2023: € 592,370 ▲ 19% vs 2022 (€ 499,711) Favourable step	€ 928,008 Cash 2024: € 928,008 ▲ 57% vs 2023 (€ 592,370) Favourable step	€ 1,183,962 Cash 2025: € 1,183,962 ▲ 28% vs 2024 (€ 928,008) Favourable step	▲ 28%
Retained profit	€ 769,050 Retained profit 2022: € 769,050 First fiscal year in the series	€ 863,836 Retained profit 2023: € 863,836 ▲ 12% vs 2022 (€ 769,050) Favourable step	€ 1,002,299 Retained profit 2024: € 1,002,299 ▲ 16% vs 2023 (€ 863,836) Favourable step	€ 1,000,115 Retained profit 2025: € 1,000,115 Unchanged (€ 1,002,299) Unfavourable step
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 255,000 Dividend 2025: € 255,000 Unchanged (€ 0) Unchanged
Balance sheet total	€ 3,255,561 Balance sheet total 2022: € 3,255,561 First fiscal year in the series	€ 3,348,220 Balance sheet total 2023: € 3,348,220 ▲ 3% vs 2022 (€ 3,255,561) Unchanged	€ 3,483,858 Balance sheet total 2024: € 3,483,858 ▲ 4% vs 2023 (€ 3,348,220) Unchanged	€ 3,739,812 Balance sheet total 2025: € 3,739,812 ▲ 7% vs 2024 (€ 3,483,858) Unchanged	▲ 7%

Key figures of PHARMAPRO, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMAPRO?

What happened at PHARMAPRO in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 10, 2026 New annual accounts for financial year 2025: profit of € 252,816 (▲ 83% vs 2024). Source: NBB ↗
Jul 8, 1998 New establishment in Eupen. KBO
Jul 22, 1997 Start of the company according to the CBE. KBO

In short

From € 92,320 profit in 2022 to € 252,816 profit in 2025.

Paid € 8 in corporate taxes since 2022.

Best year ever: 2025, with € 252,816 profit.

Paid out € 255,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Establishments

Establishment units

Physical locations of this company

Registered office

Auenweg 11

4700 Eupen

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0461.179.570
VAT number: BE 0461.179.570
Registered office: Auenweg 11, 4700 Eupen
Names & denominations: PHARMAPRO
Enterprise type: Rechtspersoon
Legal form: Public limited company
Legal situation: Normale toestand
Start date: 22 July 1997
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMAPRO